These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 29971044
1. The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis. Lontos K, Adamik J, Tsagianni A, Galson DL, Chirgwin JM, Suvannasankha A. Front Endocrinol (Lausanne); 2018; 9():322. PubMed ID: 29971044 [Abstract] [Full Text] [Related]
2. Inhibition of Semaphorin 4D/Plexin-B1 signaling inhibits the subchondral bone loss in early-stage osteoarthritis of the temporomandibular joint. Zhang Z, Lu L, Ye T, Yu S, Zhang J, Zhang M, He F, Liu Q, Yang H, Feng J. Arch Oral Biol; 2022 Mar; 135():105365. PubMed ID: 35151027 [Abstract] [Full Text] [Related]
3. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion. Cao J, Zhang C, Chen T, Tian R, Sun S, Yu X, Xiao C, Wang G, Liu Y, Fu M, Li W. J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877 [Abstract] [Full Text] [Related]
4. Dual-Function Semaphorin 4D Released by Platelets: Suppression of Osteoblastogenesis and Promotion of Osteoclastogenesis. Shindo S, Savitri IJ, Ishii T, Ikeda A, Pierrelus R, Heidari A, Okubo K, Nakamura S, Kandalam U, Rawas-Qalaji M, Leon E, Pastore MR, Hardigan P, Kawai T. Int J Mol Sci; 2022 Mar 09; 23(6):. PubMed ID: 35328359 [Abstract] [Full Text] [Related]
5. The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases. Wu M, Li J, Gao Q, Ye F. Expert Opin Ther Targets; 2016 Jul 09; 20(7):885-901. PubMed ID: 26732941 [Abstract] [Full Text] [Related]
6. Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer. Yang YH, Buhamrah A, Schneider A, Lin YL, Zhou H, Bugshan A, Basile JR. PLoS One; 2016 Jul 09; 11(2):e0150151. PubMed ID: 26910109 [Abstract] [Full Text] [Related]
7. Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma. Terpos E, Ntanasis-Stathopoulos I, Christoulas D, Bagratuni T, Bakogeorgos M, Gavriatopoulou M, Eleutherakis-Papaiakovou E, Kanellias N, Kastritis E, Dimopoulos MA. Blood Cancer J; 2018 May 11; 8(5):42. PubMed ID: 29748532 [Abstract] [Full Text] [Related]
8. Semaphorin 4D Enhances Angiogenic Potential and Suppresses Osteo-/Odontogenic Differentiation of Human Dental Pulp Stem Cells. Zou T, Dissanayaka WL, Jiang S, Wang S, Heng BC, Huang X, Zhang C. J Endod; 2017 Feb 11; 43(2):297-305. PubMed ID: 28027822 [Abstract] [Full Text] [Related]
9. Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. Okuno T, Nakatsuji Y, Moriya M, Takamatsu H, Nojima S, Takegahara N, Toyofuku T, Nakagawa Y, Kang S, Friedel RH, Sakoda S, Kikutani H, Kumanogoh A. J Immunol; 2010 Feb 01; 184(3):1499-506. PubMed ID: 20038643 [Abstract] [Full Text] [Related]
10. Estrogen-dependent proteolytic cleavage of semaphorin 4D and plexin-B1 enhances semaphorin 4D-induced apoptosis during postnatal vaginal remodeling in pubescent mice. Ito T, Bai T, Tanaka T, Yoshida K, Ueyama T, Miyajima M, Negishi T, Kawasaki T, Takamatsu H, Kikutani H, Kumanogoh A, Yukawa K. PLoS One; 2014 Feb 01; 9(5):e97909. PubMed ID: 24841081 [Abstract] [Full Text] [Related]
11. Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR. Gene; 2011 Dec 10; 489(2):63-9. PubMed ID: 21925246 [Abstract] [Full Text] [Related]
12. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Evans EE, Jonason AS, Bussler H, Torno S, Veeraraghavan J, Reilly C, Doherty MA, Seils J, Winter LA, Mallow C, Kirk R, Howell A, Giralico S, Scrivens M, Klimatcheva K, Fisher TL, Bowers WJ, Paris M, Smith ES, Zauderer M. Cancer Immunol Res; 2015 Jun 10; 3(6):689-701. PubMed ID: 25614511 [Abstract] [Full Text] [Related]
13. The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4. Zhou H, Yang YH, Basile JR. Angiogenesis; 2014 Jan 10; 17(1):261-74. PubMed ID: 24114199 [Abstract] [Full Text] [Related]
14. Grb2 mediates semaphorin-4D-dependent RhoA inactivation. Sun T, Krishnan R, Swiercz JM. J Cell Sci; 2012 Aug 01; 125(Pt 15):3557-67. PubMed ID: 22505611 [Abstract] [Full Text] [Related]
15. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H, Yang Y, Xiao J, Yang S, Liu Y, Kang W, Li X, Zhang F. Microvasc Res; 2014 May 01; 93():1-8. PubMed ID: 24603190 [Abstract] [Full Text] [Related]
16. Reduced expression of semaphorin 4D and plexin-B in breast cancer is associated with poorer prognosis and the potential linkage with oestrogen receptor. Malik MF, Ye L, Jiang WG. Oncol Rep; 2015 Aug 01; 34(2):1049-57. PubMed ID: 26035216 [Abstract] [Full Text] [Related]
17. Plexin B1 inhibits MET through direct association and regulates Shp2 expression in melanocytes. Soong J, Scott G. J Cell Sci; 2013 Jan 15; 126(Pt 2):688-95. PubMed ID: 23203808 [Abstract] [Full Text] [Related]
18. An antagonistic monoclonal anti-Plexin-B1 antibody exerts therapeutic effects in mouse models of postmenopausal osteoporosis and multiple sclerosis. Vogler M, Oleksy A, Schulze S, Fedorova M, Kojonazarov B, Nijjar S, Patel S, Jossi S, Sawmynaden K, Henry M, Brown R, Matthews D, Offermanns S, Worzfeld T. J Biol Chem; 2022 Sep 15; 298(9):102265. PubMed ID: 35850304 [Abstract] [Full Text] [Related]
19. Roles of Sema4D and Plexin-B1 in tumor progression. Ch'ng ES, Kumanogoh A. Mol Cancer; 2010 Sep 21; 9():251. PubMed ID: 20858260 [Abstract] [Full Text] [Related]
20. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Basile JR, Castilho RM, Williams VP, Gutkind JS. Proc Natl Acad Sci U S A; 2006 Jun 13; 103(24):9017-22. PubMed ID: 16754882 [Abstract] [Full Text] [Related] Page: [Next] [New Search]